Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam J Shaywitz

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Science'S STKE : Signal Transduction Knowledge Environment|July 26, 2002
Analysis of phosphorylation-dependent protein-protein interactions using a bacterial two-hybrid systemAdam J Shaywitz, Simon L Dove, Michael E Greenberg, et al.
Cell Metabolism|September 3, 2008
PI3K enters beta-testingAdam J Shaywitz, Kevin D Courtney, Akash Patnaik, et al.
Pediatric Neurology|January 17, 2017
Intracerebroventricular Delivery as a Safe, Long-Term Route of Drug AdministrationJessica L Cohen-Pfeffer, Sridharan Gururangan, Thomas Lester, et al.
Pediatric Research|September 3, 2015
Safety and clinical activity of elosulfase alfa in pediatric patients with Morquio A syndrome (mucopolysaccharidosis IVA) less than 5 ySimon A Jones, Martin Bialer, Rossella Parini, et al.
Clinical Pharmacokinetics|September 20, 2014
Pharmacokinetic and pharmacodynamic evaluation of elosulfase alfa, an enzyme replacement therapy in patients with Morquio A syndromeYulan Qi, Donald G Musson, Becky Schweighardt, et al.
Molecular Genetics and Metabolism|May 26, 2018
Best practices for the use of intracerebroventricular drug delivery devicesIrene Slavc, Jessica L Cohen-Pfeffer, Sridharan Gururangan, et al.
Clinical Therapeutics|December 10, 2014
Immunogenicity of Elosulfase Alfa, an Enzyme Replacement Therapy in Patients With Morquio A Syndrome: Results From MOR-004, a Phase III TrialBecky Schweighardt, Troy Tompkins, Kelly Lau, et al.
Neuron|April 24, 2002
CREB transcriptional activity in neurons is regulated by multiple, calcium-specific phosphorylation eventsJon M Kornhauser, Christopher W Cowan, Adam J Shaywitz, et al.
Orphanet Journal of Rare Diseases|June 28, 2017
Recommendations on clinical trial design for treatment of Mucopolysaccharidosis Type IIIArunabha Ghosh, Elsa Shapiro, Stewart Rust, et al.
Cell Metabolism|August 8, 2014
Grizzly bears exhibit augmented insulin sensitivity while obese prior to a reversible insulin resistance during hibernationO Lynne Nelson, Heiko T Jansen, Elizabeth Galbreath, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Science'S STKE : Signal Transduction Knowledge Environment|July 26, 2002
Analysis of phosphorylation-dependent protein-protein interactions using a bacterial two-hybrid systemAdam J Shaywitz, Simon L Dove, Michael E Greenberg, et al.
Cell Metabolism|September 3, 2008
PI3K enters beta-testingAdam J Shaywitz, Kevin D Courtney, Akash Patnaik, et al.
Pediatric Neurology|January 17, 2017
Intracerebroventricular Delivery as a Safe, Long-Term Route of Drug AdministrationJessica L Cohen-Pfeffer, Sridharan Gururangan, Thomas Lester, et al.
Pediatric Research|September 3, 2015
Safety and clinical activity of elosulfase alfa in pediatric patients with Morquio A syndrome (mucopolysaccharidosis IVA) less than 5 ySimon A Jones, Martin Bialer, Rossella Parini, et al.
Clinical Pharmacokinetics|September 20, 2014
Pharmacokinetic and pharmacodynamic evaluation of elosulfase alfa, an enzyme replacement therapy in patients with Morquio A syndromeYulan Qi, Donald G Musson, Becky Schweighardt, et al.
Molecular Genetics and Metabolism|May 26, 2018
Best practices for the use of intracerebroventricular drug delivery devicesIrene Slavc, Jessica L Cohen-Pfeffer, Sridharan Gururangan, et al.
Clinical Therapeutics|December 10, 2014
Immunogenicity of Elosulfase Alfa, an Enzyme Replacement Therapy in Patients With Morquio A Syndrome: Results From MOR-004, a Phase III TrialBecky Schweighardt, Troy Tompkins, Kelly Lau, et al.
Neuron|April 24, 2002
CREB transcriptional activity in neurons is regulated by multiple, calcium-specific phosphorylation eventsJon M Kornhauser, Christopher W Cowan, Adam J Shaywitz, et al.
Orphanet Journal of Rare Diseases|June 28, 2017
Recommendations on clinical trial design for treatment of Mucopolysaccharidosis Type IIIArunabha Ghosh, Elsa Shapiro, Stewart Rust, et al.
Cell Metabolism|August 8, 2014
Grizzly bears exhibit augmented insulin sensitivity while obese prior to a reversible insulin resistance during hibernationO Lynne Nelson, Heiko T Jansen, Elizabeth Galbreath, et al.
Pageof 2